Home/Filings/4/0001213900-24-020830
4//SEC Filing

BENDER LEWIS H 4

Accession 0001213900-24-020830

CIK 0001567264other

Filed

Mar 6, 7:00 PM ET

Accepted

Mar 7, 6:01 PM ET

Size

7.8 KB

Accession

0001213900-24-020830

Insider Transaction Report

Form 4
Period: 2024-03-06
BENDER LEWIS H
DirectorPresident and CEO10% Owner
Transactions
  • Award

    Stock Option (right to buy Common Stock)

    2024-03-06+33,57433,574 total
    Exercise: $5.19Exp: 2034-03-06Common Stock (33,574 underlying)
  • Award

    Stock Option (right to buy Common Stock)

    2024-03-06+464,805464,805 total
    Exercise: $5.19Exp: 2034-03-06Common Stock (464,805 underlying)
Footnotes (2)
  • [F1]This option will vest, subject to the individual's continued employment with Intensity Therapeutics, Inc., in four, equal, annual installments, beginning on March 6, 2024.
  • [F2]This option vested 100% on March 6, 2024.

Documents

1 file

Issuer

INTENSITY THERAPEUTICS, INC.

CIK 0001567264

Entity typeother

Related Parties

1
  • filerCIK 0001238705

Filing Metadata

Form type
4
Filed
Mar 6, 7:00 PM ET
Accepted
Mar 7, 6:01 PM ET
Size
7.8 KB